ArticleMolecular oncology2015

Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth.

Sonam Dilwali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.